Licensing opportunities from Athenion
Athenion owns and develops a unique portfolio of advanced-stage therapeutics and medical technologies. For all of our portfolio products, we own the exclusive development, marketing and licensing rights in Europe, North-America, Japan and a number of other countries.
All of our compounds, technologies and products are in an advanced stage of development - some have already regulatory market approval in certain countries.
Athenion offers these technologies for in-licensing to partners from health care, medical technology and related industries. We look for partners that have proven scientific and marketing competence in the particular field of application.
Our current out-licensing portfolio consists of offerings in the following fields/markets:
- Non-Alzheimer age-related dementia
- CNS Trauma
- Brain Edema
- Enhancement of cognitive functions, attention, stress tolerance
- anti-inflammatory/cytokine inhibition
- wound healing - reduction of scar (keloid) formation
- Restoration of oxygenation/perfusion in compromised tissues
- Hepatitis B, C, D
- Pain-level monitoring for anesthesia
- Attention monitoring for drivers (automotive vigilance surveillance, sleep prevention)
Non-prescription, OTC and Supplements